Navigation Links
Spinal Non-Fusion Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2017
Date:11/22/2011

t Dynamics 29

6.9.1 Market Driver 29

6.9.2 Market Restraint 29

7 Spinal Non-Fusion Devices Market, Analysis and Forecasts by Country 30

7.1 Spinal Non-Fusion Devices Market, The US, Revenue ($m), Historic, 2003?2010 30

7.2 Spinal Non-Fusion Devices Market, The US, Revenue ($m), Forecast, 2010?2017 31

7.3 Spinal Non-Fusion Devices Market, Canada, Revenue ($m), Historic, 2003?2010 32

7.4 Spinal Non-Fusion Devices Market, Canada, Revenue ($m), Forecast, 2010?2017 33

7.5 Spinal Non-Fusion Devices Market, The UK, Revenue ($m), Historic, 2003?2010 34

7.6 Spinal Non-Fusion Devices Market, The UK, Revenue ($m), Forecast, 2010?2017 35

7.7 Spinal Non-Fusion Devices Market, Germany, Revenue ($m), Historic, 2003?2010 36

7.8 Spinal Non-Fusion Devices Market, Germany, Revenue ($m), Forecast, 2010?2017 37

7.9 Spinal Non-Fusion Devices Market, France, Revenue ($m), Historic, 2003?2010 38

7.10 Spinal Non-Fusion Devices Market, France, Revenue ($m), Forecast, 2010?2017 39

7.11 Spinal Non-Fusion Devices Market, Italy, Revenue ($m), Historic, 2003?2010 40

7.12 Spinal Non-Fusion Devices Market, Italy, Revenue ($m), Forecast, 2010?2017 41

7.13 Spinal Non-Fusion Devices Market, Spain, Revenue ($m), Historic, 2003?2010 42

7.14 Spinal Non-Fusion Devices Market, Spain, Revenue ($m), Forecast, 2010?2017 43

7.15 Spinal Non-Fusion Devices Market, China, Revenue ($m), Historic, 2003?2010 44

7.16 Spinal Non-Fusion Devices Market, China, Revenue ($m), Forecast, 2010?2017 45

7.17 Spinal Non-Fusion Devices Market, India, Revenue ($'000), Historic, 2003?2010 46

7.18 Spinal Non-Fusion Devices Market, India, Revenue ($'000), Forecast, 2010?2017 47

7.19 Spinal Non-Fusion Devices Market, Australia, Revenue ($m), Historic, 2003?2010 48

7.20 Spinal Non-Fusion Devices Market, Australia, Revenue ($m), Forecast, 2010?2017 49

7.21 Spinal Non-Fus
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Alseres Pharmaceuticals Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial
2. Mayo Clinic Clarifies Diagnosis and Treatment for Rare, Serious Blood Vessel Disease of Brain and Spinal Cord
3. Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa Clinical Trial in Acute Spinal Cord Injury
4. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
5. Genzyme Genetics Announces Launch of Carrier Testing and Prenatal Diagnosis for Spinal Muscular Atrophy
6. CoreSpine Technologies Expands Spinal Disc Site Preparation Efforts
7. Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury
8. Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications
9. New Minimally Invasive Surgical Procedure Restores Quality of Life in Patients With Potentially Debilitating Spinal Condition
10. Markers in Blood and Spinal Fluid, and a New Imaging Agent, Show Promise for Early Detection of Alzheimers
11. Neuralstem Licenses Cleveland Clinic Spinal Cord Injection Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... Cali ., Aug. 22, 2014  Research presented ... that a therapy being developed by Hera Therapeutics Inc. combats ... 70 percent of all cervical cancer. When tested ... of HPV-16, HPV-18 and HPV-11 cells, according to Louise ... who presented the findings at the Seattle ...
(Date:8/22/2014)... , Aug. 22, 2014  Cannabis Science, ... cannabis formulation-based drug development and related consulting, is ... third international medical cannabis conference taking place at ... France , on October 22, 2014.  The ... stakeholders, such as researchers, health professionals, and patients, ...
(Date:8/22/2014)...  WaferGen Bio-systems, Inc. (NASDAQ: WGBS) today announced the ... common stock and warrants at a price of $10,000 ... to deducting underwriting discounts and commissions and offering expenses ... immediately separable and will be issued separately.  The shares ... The NASDAQ Stock Market under the ticker symbol "WGBS" ...
Breaking Medicine Technology:Study shows Hera Therapeutics experimental compound shuts down human papillomavirus that causes most cervical cancer 2Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 2Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4
... 2011 Sigma-Aldrich Corporation (NASDAQ: SIAL ) ... unit, SAFC® ( www.safcglobal.com ), is introducing a novel ... (CHO) cell line. Designed for use in the production ... the first commercially available glutamine synthetase (GS) knockout CHO ...
... YORK, Oct. 27, 2011 Reportlinker.com ... report is available in its catalogue: ... Reimbursement Outlook: Optimizing price and market ... http://www.reportlinker.com/p0165652/Pharma-Pricing-and-Reimbursement-Outlook-Optimizing-price-and-market-access-in-a-recessionary-climate.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Health_Insurance ...
Cached Medicine Technology:SAFC Introduces the First Commercially Available Novel CHOZN® GS Knockout CHO Cell Line 2SAFC Introduces the First Commercially Available Novel CHOZN® GS Knockout CHO Cell Line 3SAFC Introduces the First Commercially Available Novel CHOZN® GS Knockout CHO Cell Line 4Pharma Pricing and Reimbursement Outlook: Optimizing price and market access in a recessionary climate 2Pharma Pricing and Reimbursement Outlook: Optimizing price and market access in a recessionary climate 3Pharma Pricing and Reimbursement Outlook: Optimizing price and market access in a recessionary climate 4Pharma Pricing and Reimbursement Outlook: Optimizing price and market access in a recessionary climate 5
(Date:8/22/2014)... Las Vegas, NV (PRWEB) August 22, 2014 ... that teaches readers how they can use natural methods ... for years has caught the attention of Shane Michaels, ... only a condition that affects the skin, it can ... suffer from it,” reports Michaels. “The intense itching and ...
(Date:8/22/2014)... receptor (EGFR) mutations found in the circulating free tumor ... lung cancer (NSCLC) patients correlates well with the EGFR ... kinase inhibitor (TKI) therapy is approved for EGFR activating ... for determining mutation status is with DNA derived directly ... available. A more abundant and less invasive source of ...
(Date:8/22/2014)... Advancements in ultrasound technologies make ... due to their cost-effectiveness, non-invasiveness, and absence of ... such as the evolution of wireless transducers and ... market moving throughout 2014 and beyond. Such Ultrasound’s ... only the point-of-care (POC) testing in hospital settings, ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 CarePoint ... specialist in Internal Medicine, Geriatrics, Hospice and Palliative ... CarePoint Health Medical Group. Their system welcomes Dr. ... and experienced physicians comprise CarePoint Health Medical Group, ... in Hudson County, representing a wide range of ...
(Date:8/22/2014)... West Orange, NJ. August 22, 2014. A ... shows that persons with multiple sclerosis (MS) may ... cognitive rehabilitation. The study was epublished ahead of ... (Yael Goverover, Helen Genova, Hali Griswold, Nancy D. ... awareness in persons with multiple sclerosis doi: 10.3233/NRE-141113). ...
Breaking Medicine News(10 mins):Health News:Beat Eczema: Review Exposes Susan Clark’s Guide to Curing Eczema Naturally 2Health News:High concordance between EGFR mutations from circulating-free tumor DNA and tumor tissue in non-small cell lung cancer 2Health News:Global Top Ultrasound Market Suppliers Assessed in New VPG Research Report Available at MarketPublishers.com 2Health News:Global Top Ultrasound Market Suppliers Assessed in New VPG Research Report Available at MarketPublishers.com 3Health News:Dr. Reisner Joins CarePoint Health Medical Group 2Health News:Kessler Foundation study of self-awareness in MS has implications for rehabilitation 2
... iodinated contrast media during imaging procedures is associated ... of developing hyperthyroidism, according to a report in ... Internal Medicine , one of the JAMA/Archives journals. ... pharmaceutical agents," the authors write as background information. ...
... Reporter , MONDAY, Jan. 23 (HealthDay News) -- Although many ... seriously hurt, the opposite may be true with traumatic brain ... traumatic brain injury in children as young as 2 years, ... even behavior for some time. However, the researchers also found ...
... who routinely accompany older adults to physician office visits ... according to a new study led by researchers at ... authors found that three-quarters of older adults who attend ... over time, nearly always by the same companion. The ...
... release is available in French . Montreal ... three times more likely to develop respiratory or gastrointestinal infections in ... as a Centre d,Hbergement de Soins de Longue Dure (CHLSD). These ... Canadian Medical Association Journal today. "There certainly seems ...
... can help fight both breast cancers and leukemias, according to ... Journal of Experimental Medicine ( http://www.jem.org ). The ... protect other proteins in the cell. , A team led ... found that blocking HSP90 activity rendered normally protected proteins vulnerable ...
... garnered accolades for rescuing skinned knees on the playground ... they,re gaining merit for their offspring,s physical health in ... the journal Psychological Science , Brandeis psychologist Margie ... of British Columbia and the University of California, Los ...
Cached Medicine News:Health News:Use of iodinated contrast media in imaging procedures appears to affect thyroid function 2Health News:Severe Brain Injury When Young May Have Long-Term Effects 2Health News:Severe Brain Injury When Young May Have Long-Term Effects 3Health News:Severe Brain Injury When Young May Have Long-Term Effects 4Health News:Going to physician visits with older loved ones could improve care 2Health News:Emergency room visits risky for elderly residents from long-term care facilities 2Health News:Nurturing mothers rear physically healthier adults 2Health News:Nurturing mothers rear physically healthier adults 3
... The 1081 is an all-in-one drape ... The drape includes a pouch with filter ... finger cot. 64 inches (164cm) TUR ... Elastic aperture, Neoprene finger cot, Fluid collection ...
... Both the Penilab IV and the Penilab V ... studies. Model 1060 is similar to the Model ... nor can one be added later. The Penilab ... including all of the accessories you'll need to get ...
The Model 240 is a single-channel instrument designed for penile tumescence monitoring. It features exceptional stability. It's ready for use with most multi-channel recorders having a DC input....
... II SP MRI-Compatible Anesthesia System is perfect for ... than one type of anesthetic agent. , ... due to its wider stance, has a larger ... bellows assembly is utilized in both the Integra ...
Medicine Products: